Annals of Oncology 2:169-182, 1991
© 1991 European Society for Medical Oncology
review-article |
Expression of transforming growth factor alpha (TGF
) in breast cancer
Laboratory of Tumor Immunology and Biology, Division of Cancer Biology and Diagnosis, National Cancer Institute, National Institutes of Health Bethesda, U.S.A.
Correspondence to: D.S.Salomon, Ph.D., Laboratory of Tumor Immunology and Biology, Division of Cancer Biology and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, U.S.A.
Transforming growth factor alpha (TGF
) is one growth factor that has been circumstantially implicated in regulating the autocrine growth of breast cancer cells. Expression of TGF can be modulated by activated cellular protooncogenes such as ras and by estrogens. For example, the epidermal growth factor (EGF)-responsive normal NOG-8 mouse and human MCF-10A mammary epithelial cell lines can be transformed with either a point-mutated c-Ha-ras protooncogene or with a normal or point-mutated c-neu (erbB-2) protoonco-gene. In ras transformed NOG-8 and MCF-10A cells but not in neu transformed cells there is a loss in or an attenuated response to the mitogenic effects of EGF. This response may be due in part to an enhanced production of endogenous TGF that is coordinately and temporally linked to the expression of the activated ras gene and to the acquisition of transformation-associated properties in these cells. TGF mRNA and TGF protein can also be detected in approximately 50–70% of primary human breast tumors. In addition, approximately 2- to 3-fold higher levels of biologically active and immunoreactive TGF can also be detected in the pleural effusions from breast cancer patients as compared with the TGFa levels in the serous effusions of noncancer patients. Over-expression of a full-length TGF cDNA in NOG-8 and MCF-10A cells is capable of transforming these cells. Finally, expression of TGF mRNA and production of biologically active TGF protein is also found in normal rodent and human mammary epithelial cells.
estrogens, mammary gland, neu, ras, transformation, TGF
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Revillion, V. Lhotellier, L. Hornez, J. Bonneterre, and J.-P. Peyrat ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis Ann. Onc., January 1, 2008; 19(1): 73 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Grana, C. I. Sartor, and A. D. Cox Epidermal Growth Factor Receptor Autocrine Signaling in RIE-1 Cells Transformed by the Ras Oncogene Enhances Radiation Resistance Cancer Res., November 15, 2003; 63(22): 7807 - 7814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Suo, B. Risberg, M. G. Karlsson, K. Villman, E. Skovlund, and J. M. Nesland The Expression of EGFR Family Ligands in Breast Carcinomas International Journal of Surgical Pathology, April 1, 2002; 10(2): 91 - 99. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Eggert, N. Ikegaki, J. Kwiatkowski, H. Zhao, G. M. Brodeur, and B. P. Himelstein High-Level Expression of Angiogenic Factors Is Associated with Advanced Tumor Stage in Human Neuroblastomas Clin. Cancer Res., May 1, 2000; 6(5): 1900 - 1908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Hansard, B. E. Healy-Gardner, A. T. Drapkin, R. C. Bentley, J. A. McLachlan, and D. K. Walmer Human Endometrial Transforming Growth Factor-{alpha}: A Transmembrane, Surface Epithelial Protein That Transiently Disappears During the Midsecretory Phase of the Menstrual Cycle Reproductive Sciences, May 1, 1997; 4(3): 160 - 166. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Buse, P. L. Woo, D. B. Alexander, H. H. Cha, A. Reza, N. D. Sirota, and G. L. Firestone Transforming Growth Factor-alpha Abrogates Glucocorticoid-stimulated Tight Junction Formation and Growth Suppression in Rat Mammary Epithelial Tumor Cells J. Biol. Chem., March 24, 1995; 270(12): 6505 - 6514. [Abstract] [Full Text] [PDF]
|
|